<?xml version="1.0" encoding="UTF-8"?>
<p>HSV-2 prevalence was found to be a proxy of HIV prevalence, acting as a ‘biomarker’ or a ‘temperature scale’ of the sexual risk behavior that drives HIV transmission in a population. This is akin to hepatitis C virus, which was shown to be a ‘temperature scale’ of the injecting risk behavior that drives HIV transmission among people who inject drugs [
 <xref rid="R46" ref-type="bibr">46</xref>–
 <xref rid="R48" ref-type="bibr">48</xref>]. HSV-2 prevalence, together with other factors such as costs and health benefits, can be used as a criterion in the prioritization, optimization, and resource allocation of HIV prevention interventions, as has been suggested previously [
 <xref rid="R15" ref-type="bibr">15</xref>]. HSV-2 prevalence can help in identifying which populations and/or sexual networks to target while designing cost-effective HIV/STI-specific prevention interventions.
</p>
